Biotech
Star Therapeutics
Star Therapeutics raises $125M Series C at $650M valuation
$125M
Total Raised
Series C
Latest Round
2020
Founded
95+
Employees
Cambridge, MA
1 min read
Quick Facts
Valuation
$650M
Latest Round Size
$125M
Latest Round Date
October 2025
Star Therapeutics: Series C Funding Round
Star Therapeutics has successfully raised $125M in Series C funding, reaching a valuation of $650M.
Company Overview
Cell therapy platform for cancer treatment
Funding Details
The Series C round was led by RA Capital, with participation from Arch Venture Partners.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2020
- Employees: 95+
- Category: Biotech
Investment
Star Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- RA Capital: Verified investor in Series C
- Arch Venture Partners: Verified investor in Series C
Key Investors
RA Capital
Lead Investor
Verified investor in Series C
Arch Venture Partners
Investor
Verified investor in Series C
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M